How Did Saffola Dominate India's Edible Oil Market?

TL;DR

Saffola dominated the ultra-premium edible oil segment by building medical credibility, educating consumers about heart risks, and expanding its message from treatment to prevention. When lower-priced rivals threatened the brand, Marico protected Saffola’s premium positioning by launching Sweekar Sunflower as a separate low-cost competitor, preserving Saffola’s margins while defending overall market share.

Transcript

hi everybody suffola is one of the most legendary companies in the indian business history in the past 21 years the stock price of its parent company mariko has shot up by 17 200 going from just 2.67 rupees to 487 rupees in 2022 and if you look at the market share of surface category it stood at an insane market share of 81 percent as of 2021 and t... Read More

Key Insights

• Saffola originated from a clear product gap: heart patients wanted refined safflower oil, but the crude oil available in the market tasted bitter, while the limited refining companies were largely unbranded and unreliable.
• First-mover advantage did not eliminate Saffola’s marketing challenge because consumers and medical professionals initially lacked awareness of the product. The company therefore needed to educate the market about both safflower oil and heart health before demand could grow.
• Medical credibility was central to Saffola’s early growth. The brand worked with institutions including Escorts Health Institute and Bombay Hospital, held conferences among cardiologists, and sought recommendations that could convert heart patients into long-term customers.
• Consumer education created trust before purchase. Saffola organized awareness campaigns, free cholesterol checks, and a Dial-a-Dietitian program, providing advice about diet and lifestyle that positioned the brand as dependable and concerned with customer health.
• Heart disease prevention offered a market described as ten times larger than the existing patient segment. Saffola expanded its audience by highlighting obesity, hypertension, diabetes, and smoking as four risk factors through television, radio, and newspaper campaigns.
• Household decision-makers shaped Saffola’s advertising strategy. Commercials portrayed wives concerned about the health of men over 45 who were obese, recognizing that men might consume the oil while women commonly decided which cooking oil the household purchased.
• A separate low-cost brand protected Saffola’s premium positioning. Instead of cutting Saffola’s price when HUL and ITC offered products five to ten percent cheaper, Marico introduced Sweekar Sunflower to compete directly in the lower-priced segment.
• Premium margins mattered more than volume alone. By 1998, Sweekar generated revenue of 100 crore rupees and sold three times Saffola’s volume, yet contributed only one-third of Saffola’s unit margin, demonstrating the profitability of Saffola’s premium position.

Questions & Answers

Q: How did Saffola become a leading edible oil brand in India?

Saffola became a leading brand by addressing demand for refined safflower oil, establishing credibility with doctors and medical institutions, and educating consumers about heart health. It supported awareness campaigns, free cholesterol checks, cardiologist conferences, and a Dial-a-Dietitian service. The brand then expanded from serving heart patients to targeting people who wanted to prevent heart disease, creating a substantially larger market.

Q: Why was there an opportunity for refined safflower oil in India?

The opportunity arose because medical research had identified safflower oil as beneficial to heart health due to its higher proportion of polyunsaturated fatty acids. However, consumers mainly had access to crude safflower oil, which tasted very bitter. Refining companies were scarce, unbranded, and unreliable, leaving patients to seek local refining arrangements or remove oil from their diets.

Q: How did Saffola earn the trust of doctors and patients?

Saffola built trust by working with leading medical institutions, including Escorts Health Institute and Bombay Hospital, and by holding conferences within cardiologist circles. It also conducted heart-health campaigns, offered free cholesterol checks, and created a Dial-a-Dietitian program. These activities delivered health information and practical assistance before asking consumers to purchase, strengthening the brand’s dependable and authentic image.

Q: Why did Saffola shift its marketing from treatment to prevention?

The company recognized that heart patients formed a relatively small market for an FMCG product and that focusing only on them could make Saffola appear to be a medical product for sick people. Consumers interested in preventing heart disease represented a market described as ten times larger. Saffola therefore promoted awareness of obesity, hypertension, diabetes, and smoking as major risk factors.

Q: How did Saffola advertising influence household purchases?

Saffola’s advertising distinguished between the consumer and the purchasing decision-maker. Some commercials focused on obese men over 45 whose wives were concerned about their health. Although the man was presented as the primary consumer, women were portrayed as choosing the household’s cooking oil. The campaigns used concern about future heart problems to encourage families to switch brands.

Q: How did Marico respond to lower-priced competition from HUL and ITC?

Marico did not reduce Saffola’s price or simply accept the loss of market share. Instead, it introduced Sweekar Sunflower as a lower-cost brand that could compete with HUL’s Flora and ITC’s Sun Drop on price, media presence, distribution reach, and other market factors. This approach defended the lower segment without weakening Saffola’s premium identity or sacrificing its strong margins.

Q: Why would cutting Saffola’s price have damaged the brand?

Cutting the price would have reduced Saffola’s substantial profit margins and weakened its ultra-premium positioning. The transcript illustrates that selling 10 crore units for 10 rupees less would immediately reduce revenue by 100 crore rupees. After conditioning consumers to a lower price, the company also could not easily restore the original premium without resistance, making discounting strategically risky.

Q: What results did the Saffola and Sweekar strategy produce?

Saffola and Sweekar jointly became the leading refined edible oil brand combination with a 14 percent market share by 1991. By 1998, Sweekar was the second-largest brand after ITC’s Sun Drop, generated revenue of 100 crore rupees, and sold three times Saffola’s volume. Despite that scale, Sweekar contributed only one-third of Saffola’s unit margin, highlighting Saffola’s profitability.

Summary & Key Takeaways

• Saffola began after the Mariwala family recognized unmet demand for refined safflower oil among heart patients. The available crude oil tasted bitter, refining options were scarce and unreliable, and doctors lacked a dependable product to recommend. Bombay Oil Company responded by launching Saffola in 1965 as a branded, refined alternative.

• Saffola built trust through doctors, hospitals, cardiologists, health campaigns, free cholesterol checks, and a Dial-a-Dietitian program. It later expanded beyond existing patients to the much larger prevention market. Consistent television, radio, and newspaper messaging connected the brand with reducing heart disease risks such as obesity, hypertension, diabetes, and smoking.

• When HUL’s Flora and ITC’s Sun Drop competed through intensive advertising and prices five to ten percent below Saffola, Marico avoided discounting its premium brand. It launched Sweekar Sunflower for the lower-priced segment. Together, Sweekar and Saffola reached a 14 percent refined edible oil market share by 1991 while preserving Saffola’s stronger margins.